It is noteworthy that the latest report has revealed that FXR promotes non-small-cell lung cancer metastasis by activating the Jak2/STAT3 signaling pathway through the transactivation of the IL6ST and IL6 genes [50]. The gene discussed is STAT3; the disease is non-small cell lung carcinoma.